TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
LNTH

Lantheus Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

99.70$ -0.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LNTH
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– 29.7% 30.3% 32.5% 37.2% 43.3% 38.5% 44.4% 42.6% 21.2% 27.3% 51.3% 65.8% 67.0% 40.4%
– 10.3% 7.1% 7.9% 11.8% 20.0% 19.9% 25.8% 22.9% 9.2% 11.4% 31.5% 43.2% 46.1% 16.1%
– 10.3% 7.1% 7.9% 11.8% 20.0% 19.9% 25.8% 22.9% 9.2% 11.4% 31.5% 43.2% 46.1% 16.1%
– 12.2% 15.0% 16.7% 15.4% 14.4% 10.5% 9.9% 10.7% 6.2% 10.3% 16.2% 17.2% 16.2% 16.1%
– 5.6% 7.0% 6.2% 6.4% 6.9% 6.8% 7.5% 7.2% 4.1% 4.1% 2.7% 3.9% 3.4% 2.9%
– – 37.4% 38.5% 35.7% 36.8% 24.2% 24.5% 28.9% 13.8% 13.5% 10.7% – – –
– 4.8% 6.0% 6.3% 6.5% 6.1% 4.1% 3.6% 3.9% 6.7% 7.1% 4.6% 3.7% 3.1% 10.8%
– 21.3% 14.0% 11.9% 12.2% 5.9% 3.1% 2.1% 1.8% 43.2% 40.3% 23.9% 9.2% 8.2% 32.4%
– 153.3% 190.1% 195.9% 176.4% 141.6% 93.9% 83.9% 71.8% 40.9% 46.2% 66.2% 50.6% 45.1% 51.1%
– 17.3% 21.3% 19.4% 14.7% 17.1% 12.2% 12.0% 16.3% 9.3% 10.5% 18.7% 11.3% 12.1% 15.0%
– 9.0% 3.1% 3.2% 1.5% 1.4% 0.7% 0.6% 2.5% 2.4% 1.3% 0.0% 0.0% 0.0% 0.0%
– 5.8% 6.9% 6.3% 4.8% 7.4% 4.5% 4.1% 4.6% 1.9% 2.4% 1.6% 2.5% 1.7% 1.9%
– – 152.7% 160.0% 144.3% 107.3% 69.1% 60.0% 45.3% 22.7% 18.9% 42.2% 34.0% 28.5% 25.5%
– -53.3% -90.1% -95.9% -76.4% -41.6% 6.1% 16.1% 28.2% 59.1% 53.8% 33.8% 49.4% 54.9% 48.9%
– -86.0% -130.4% -138.0% -148.2% -129.9% -54.5% -38.2% -33.6% -17.2% -25.6% -14.6% 8.1% 22.5% 30.5%
– 5.6% 7.0% 7.2% 10.1% 12.8% 10.1% 9.0% 9.9% 6.2% 7.8% 5.3% 4.3% 3.6% 3.1%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?